Effects of the Sodium‐Glucose Cotransporter‐2 Inhibitor Velagliflozin on Insulin Concentrations in Horses With Insulin Dysregulation

ABSTRACT Background Sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are promising treatments to manage hyperinsulinemia in horses with insulin dysregulation (ID). Hypothesis The SGLT2i velagliflozin decreases insulin concentration in horses with ID. Animals Privately‐owned adult horses (n = 37) w...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Kristen Thane, Rebecca Voth, Rebecca Klee, Tobias Warnken, Victor Chukwu, Nicholas Frank
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Oxford University Press 2025-11-01
Reeks:	Journal of Veterinary Internal Medicine
Onderwerpen:	endocrinology equine metabolic syndrome insulin dysregulation laminitis oral sugar test
Online toegang:	https://doi.org/10.1111/jvim.70256
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!